Concepedia

Dedong Zhu

DZ

Statistics

Publications

10

Citations

277

H-Index

10

Active since

2015

Affiliations

Ningbo No. 2 Hospital(Current)

Ningbo University

Zhejiang Cancer Hospital

Wenzhou Medical University

Zhejiang University

Dedong Zhu is an author at Ningbo No. 2 Hospital specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2015–2023

10

Publications

10

Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC–MS/MS

Xiaojun Shi, Dedong Zhu, Jie Lou et al. · Journal of Chromatography B · 2015 · 78 citations

, , +7

CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study

X. Zhang, Jian Zhou, Dedong Zhu et al. · Clinical & Translational Oncology · 2018 · 41 citations

, , +9

Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres<sup>®</sup> in 275 Hepatocellular Carcinoma Patients: Results From the Chinese CalliSpheres<sup>®</sup> Transarterial Chemoembolization in Liver Cancer (CTILC) Study

Junhui Sun, Xiaoxi Xie, Wenjiang Gu et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2019 · 27 citations · Full text

, , +15

The clinical significance of serum chitinase 3‐like 1 in hepatitis B–related chronic liver diseases

Zhenluo Jiang, Shuwei Wang, Jian-Cheng Jin et al. · Journal of Clinical Laboratory Analysis · 2020 · 25 citations · Full text

, , +17

The Comprehensive Analysis of Efficacy and Safety of CalliSpheres<sup>®</sup> Drug-Eluting Beads Transarterial Chemoembolization in 367 Liver Cancer Patients: A Multiple-Center, Cohort Study

Zhiyi Peng, Guohong Cao, Ling Li et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2019 · 24 citations · Full text

, , +15

1–5 of 10